8-K Announcements
6Material company update
Mar 16, 2026·SEC
Material company update
Mar 6, 2026·SEC
Material company update
Mar 3, 2026·SEC
Quipt Home Medical Corp.(QIPT)Earnings, Financials & Key Ratios
QIPT•NASDAQ
$3.65
$161M mkt cap·Price updated May 1, 2026
AboutQuipt Home Medical Corp. provides in-home medical equipment and supplies, and respiratory and durable medical equipment in the United States. The company also offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. In addition, it provides nebulizers, oxygen concentrators, CPAP and BiPAP units, ventilator equipment and aids, daily and ambulatory aides, equipment solutions, power wheelchairs, oxygen therapy, bariatric equipment, bathroom safety products, bilevel positive airway pressure, canes/crutches, continuous positive airway pressure, CPAP masks and accessories, hospital beds, humidifiers, compressors, patient lifts, walkers, products for wound care, and medical equipment for home-based sleep apnea and chronic obstructive pulmonary disease treatments, as well as rents respiratory equipment. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. was incorporated in 1993 and is headquartered in Wilder, Kentucky.Show more
- Revenue$245M-0.2%
- EBITDA$42M-19.0%
- Net Income-$11M-58.2%
- EPS (Diluted)-0.25-56.3%
- Gross Margin97.53%+35.5%
- EBITDA Margin17.05%-18.9%
- Operating Margin-1.56%-443.6%
- Net Margin-4.36%-58.6%
- ROE-9.76%-57.5%
- ROIC-1.4%-421.0%
- Debt/Equity1.06+13.8%
- Interest Coverage-0.57-575.0%
QIPT Key Insights
Quipt Home Medical Corp. (QIPT) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Momentum leader: RS Rating 89 (top 11%)
- ✓Strong 5Y sales CAGR of 27.4%
- ✓Trading near 52-week high
- ✓Trading at only 1.4x book value
✗Weaknesses
No significant weaknesses identified
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
QIPT Price & Volume
Quipt Home Medical Corp. (QIPT) stock price & volume — 10-year historical chart
Loading chart...
QIPT Growth Metrics
Quipt Home Medical Corp. (QIPT) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years16.47%
5 Years27.38%
3 Years20.61%
TTM19.78%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-61.83%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-56.12%
Return on Capital
10 Years-7.39%
5 Years1.25%
3 Years0.97%
Last Year-1.83%
QIPT Recent Earnings
Quipt Home Medical Corp. (QIPT) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 2/12 qtrs (17%)●Beat Revenue 1/12 qtrs (8%)
Q1 2026Latest
Feb 10, 2026EPS
$0.02
Est $0.10
+80.0%
Revenue
$76M
Est $76M
+0.0%
Q4 2025
Dec 15, 2025EPS
$0.08
Est $0.03
-152.6%
Revenue
$68M
Est $105M
-35.7%
Q3 2025
Aug 11, 2025EPS
$0.07
Est $0.07
-2.1%
Revenue
$43M
Est $87M
-51.3%
Q2 2025
May 12, 2025EPS
$0.07
Est $0.02
-450.0%
Revenue
$40M
Est $88M
-54.6%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q1 2026Latest | Feb 10, 2026 | $0.02vs $0.10+80.0% | $76Mvs $76M+0.0% |
| Q4 2025 | Dec 15, 2025 | $0.08vs $0.03-152.6% | $68Mvs $105M-35.7% |
| Q3 2025 | Aug 11, 2025 | $0.07vs $0.07-2.1% | $43Mvs $87M-51.3% |
| Q2 2025 | May 12, 2025 | $0.07vs $0.02-450.0% | $40Mvs $88M-54.6% |
Based on last 12 quarters of dataView full earnings history →
QIPT Peer Comparison
Quipt Home Medical Corp. (QIPT) competitors in Device suppliers, distribution, and services — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 HCSG | 1.6B | 22.31 | 27.54 | 7.08% | 3.21% | 11.83% | 0.05 | |
 EHAB | 705.89M | 13.78 | -152.10 | 2.44% | -0.3% | -0.56% | 0.89 | |
 NKTR | 1.69B | 83.37 | -8.57 | -43.89% | -297.07% | -399.1% | 1.66 | |
 INVA | 1.93B | 22.80 | 6.91 | 18.52% | 118.91% | 46.47% | 0.23 | |
 LINC | 1.39B | 44.10 | 67.85 | 17.76% | 3.86% | 10.01% | 1.02 | |
 SUPN | 3.01B | 52.28 | -76.88 | 8.63% | -3.74% | -2.73% | 0.04 | |
 PHG | 25.84B | 27.16 | 24.85 | -1.04% | 5.02% | 8.19% | 0.74 | |
 AVNS | 1.16B | 24.77 | -16.97 | 1.95% | -9.69% | -8.91% | 0.17 |
Compare QIPT vs Peers
Quipt Home Medical Corp. (QIPT) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
QIPT Income Statement
Quipt Home Medical Corp. (QIPT) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Sep'17 | Sep'18 | Sep'19 | Sep'20 | Sep'21 | Sep'22 | Sep'23 | Sep'24 | Sep'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 61.56M | 54.58M | 61.16M | 73.17M | 102.35M | 139.86M | 211.68M | 245.91M | 245.36M | 286.56M |
| Revenue Growth % | -36.09% | -11.35% | 12.07% | 19.63% | 39.88% | 36.65% | 51.35% | 16.17% | -0.23% | 19.78% |
| Cost of Goods Sold | 17.94M | 21.74M | 17.06M | 34.73M | 28.17M | 33.21M | 57.9M | 68.92M | 6.05M | 24.16M |
| COGS % of Revenue | 29.14% | 39.83% | 27.89% | 47.46% | 27.52% | 23.75% | 27.35% | 28.03% | 2.47% | - |
| Gross Profit | 43.62M▲ 0% | 37.75M▼ 13.5% | 44.1M▲ 16.8% | 38.45M▼ 12.8% | 74.18M▲ 92.9% | 106.65M▲ 43.8% | 153.78M▲ 44.2% | 176.99M▲ 15.1% | 239.31M▲ 35.2% | 242.06M▲ 0% |
| Gross Margin % | 70.86% | 69.17% | 72.11% | 52.54% | 72.48% | 76.25% | 72.65% | 71.97% | 97.53% | 84.47% |
| Gross Profit Growth % | -11.1% | -13.45% | 16.82% | -12.82% | 92.94% | 43.77% | 44.19% | 15.09% | 35.21% | - |
| Operating Expenses | 56.51M | 40.53M | 44.1M | 39.08M | 75.64M | 101.92M | 150.93M | 175.88M | 181M | 206.69M |
| OpEx % of Revenue | 91.8% | 74.26% | 72.11% | 53.41% | 73.9% | 72.87% | 71.3% | 71.52% | 73.77% | - |
| Selling, General & Admin | 28.77M | 29.5M | 22.46M | 25.04M | 49.76M | 53.82M | 82.37M | 94.69M | 97.48M | 74.28M |
| SG&A % of Revenue | 46.74% | 54.04% | 36.72% | 34.23% | 48.61% | 38.48% | 38.91% | 38.51% | 39.73% | - |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 27.74M | 11.03M | 21.64M | 14.04M | 25.88M | 48.09M | 68.56M | 81.18M | 83.52M | 4M |
| Operating Income | -12.89M▲ 0% | -5.31M▲ 58.8% | -4.63M▲ 12.9% | -634.63K▲ 86.3% | -1.46M▼ 130.1% | 4.73M▲ 424.0% | 5.76M▲ 21.7% | 1.11M▼ 80.6% | -3.82M▼ 442.9% | -2.43M▲ 0% |
| Operating Margin % | -20.94% | -9.73% | -7.56% | -0.87% | -1.43% | 3.38% | 2.72% | 0.45% | -1.56% | -0.85% |
| Operating Income Growth % | 68.25% | 58.8% | 12.9% | 86.28% | -130.06% | 424.04% | 21.68% | -80.63% | -442.87% | - |
| EBITDA | -438K | 6.37M | 5.92M | 13.9M | 16.33M | 27.77M | 45.92M | 51.67M | 41.83M | 46.49M |
| EBITDA Margin % | -0.71% | 11.68% | 9.69% | 19% | 15.95% | 19.86% | 21.69% | 21.01% | 17.05% | 16.22% |
| EBITDA Growth % | 98.54% | 1554.79% | -7.02% | 134.66% | 17.42% | 70.1% | 65.35% | 12.52% | -19.04% | -8.48% |
| D&A (Non-Cash Add-back) | 12.45M | 11.68M | 10.55M | 14.54M | 17.79M | 23.04M | 40.16M | 50.55M | 45.66M | 48.92M |
| EBIT | -20.36M | -4.97M | -4.78M | -1.74M | -7.34M | 5.01M | 4.93M | 514K | -3.6M | -2.57M |
| Net Interest Income | -1.13M | -1.48M | -3.22M | -1.86M | -1.99M | -1.92M | -7.24M | -8.55M | -6.28M | -8.26M |
| Interest Income | 0 | 1.55K | 25.68K | 0 | 0 | 0 | 366.31K | 791.49K | -467K | 376.21K |
| Interest Expense | 1.13M | 1.48M | 3.25M | 1.86M | 1.99M | 1.92M | 7.61M | 9.34M | 6.74M | 8.64M |
| Other Income/Expense | -8.59M | -1.13M | -4.25M | -2.94M | -7.87M | -1.8M | 0 | -7.77M | -6.52M | -5.01M |
| Pretax Income | -21.49M▲ 0% | -6.45M▲ 70.0% | -8.87M▼ 37.6% | -3.58M▲ 59.7% | -9.33M▼ 161.0% | 2.94M▲ 131.5% | -2.7M▼ 192.0% | -6.65M▼ 146.5% | -10.34M▼ 55.4% | -9.97M▲ 0% |
| Pretax Margin % | -34.9% | -11.81% | -14.51% | -4.89% | -9.11% | 2.1% | -1.28% | -2.71% | -4.21% | -3.48% |
| Income Tax | 354.69K | 100.62K | 203.2K | 128K | -3.15M | -1.9M | 85K | 109K | 241K | 236.38K |
| Effective Tax Rate % | -1.65% | -1.56% | -2.29% | -3.58% | 33.82% | -64.87% | -3.15% | -1.64% | -2.33% | -2.37% |
| Net Income | -19.15M▲ 0% | 14.51M▲ 175.8% | -5.58M▼ 138.4% | -4.57M▲ 18.0% | -6.17M▼ 35.0% | 4.84M▲ 178.4% | -2.78M▼ 157.5% | -6.76M▼ 142.9% | -10.7M▼ 58.2% | -10.74M▲ 0% |
| Net Margin % | -31.11% | 26.59% | -9.12% | -6.25% | -6.03% | 3.46% | -1.32% | -2.75% | -4.36% | -3.75% |
| Net Income Growth % | 66.62% | 175.76% | -138.45% | 18.05% | -35.04% | 178.38% | -157.53% | -142.92% | -58.23% | -61.83% |
| Net Income (Continuing) | -21.84M | -6.55M | -6.91M | -3.7M | -6.17M | 4.84M | -2.78M | -6.76M | -10.58M | -10.22M |
| Discontinued Operations | 0 | 0 | 1.33M | -869K | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11.7M | 12.04M |
| EPS (Diluted) | -1.02▲ 0% | 0.72▲ 170.6% | -0.27▼ 137.5% | -0.20▲ 25.9% | -0.20▲ 0.0% | 0.13▲ 165.0% | -0.07▼ 153.8% | -0.16▼ 128.6% | -0.25▼ 56.3% | -0.25▲ 0% |
| EPS Growth % | 68.42% | 170.59% | -137.5% | 25.93% | 0% | 165% | -153.85% | -128.57% | -56.25% | -56.12% |
| EPS (Basic) | -1.02 | 0.72 | -0.27 | -0.17 | -0.20 | 0.14 | -0.07 | -0.16 | -0.25 | - |
| Diluted Shares Outstanding | 18.85M | 20.19M | 20.71M | 22.72M | 30.44M | 37.22M | 39.77M | 42.5M | 43.29M | 43.61M |
| Basic Shares Outstanding | 18.85M | 20.19M | 20.71M | 28.05M | 30.44M | 34.56M | 39.77M | 42.5M | 43.29M | 43.61M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
QIPT Balance Sheet
Quipt Home Medical Corp. (QIPT) balance sheet — assets, liabilities & shareholders' equity
| Line item | Sep'17 | Sep'18 | Sep'19 | Sep'20 | Sep'21 | Sep'22 | Sep'23 | Sep'24 | Sep'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 18.36M | 17.79M | 23.25M | 45.28M | 57.23M | 41.54M | 65.43M | 73.05M | 78.35M | 78.11M |
| Cash & Short-Term Investments | 2.73M | 3.35M | 9.71M | 29.23M | 34.61M | 8.52M | 17.21M | 16.17M | 12.92M | 10.54M |
| Cash Only | 2.73M | 3.35M | 9.71M | 29.23M | 34.61M | 8.52M | 17.21M | 16.17M | 12.92M | 10.54M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 7.67M | 9.69M | 9.36M | 9.09M | 11.94M | 16.38M | 25.98M | 29.12M | 34.7M | 34.92M |
| Days Sales Outstanding | 45.5 | 64.82 | 55.84 | 45.34 | 42.57 | 42.76 | 44.79 | 43.22 | 51.62 | 40.16 |
| Inventory | 7.89M | 4.37M | 3.58M | 6.42M | 9.25M | 15.59M | 18.41M | 20.85M | 25.64M | 26.92M |
| Days Inventory Outstanding | 160.5 | 73.3 | 76.58 | 67.43 | 119.88 | 171.27 | 116.09 | 110.43 | 1.55K | 375.42 |
| Other Current Assets | -601.77K | 0 | 2.74K | -183.08K | 0 | 0 | 3.83M | 926K | 5.1M | 5.72M |
| Total Non-Current Assets | 21.18M | 20.22M | 18.42M | 26.78M | 51.34M | 90.68M | 181.97M | 173.92M | 126.59M | 124.44M |
| Property, Plant & Equipment | 16.63M | 16.17M | 14.73M | 12.48M | 23.51M | 33.5M | 53.41M | 53.86M | 64.45M | 63.77M |
| Fixed Asset Turnover | 3.70x | 3.38x | 4.15x | 5.86x | 4.35x | 4.18x | 3.96x | 4.57x | 3.81x | 4.93x |
| Goodwill | 1.43M | 1.42M | 1.42M | 2.92M | 12.46M | 28.21M | 52.83M | 50.73M | 61.56M | 61.56M |
| Intangible Assets | 3.03M | 2.53M | 2.2M | 4.18M | 14.87M | 28.89M | 74.04M | 67.95M | 77.56M | 75.89M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 118.17K | 1.4M | 1.31M | 987K | 4.16M |
| Other Non-Current Assets | 84.64K | 89.78K | 71.01K | 7.21M | 504K | 86K | 300.76K | 337K | -77.97M | -76.64M |
| Total Assets | 102.55M▲ 0% | 38.01M▼ 62.9% | 41.67M▲ 9.6% | 72.06M▲ 72.9% | 108.57M▲ 50.7% | 132.21M▲ 21.8% | 247.41M▲ 87.1% | 246.86M▼ 0.2% | 305.47M▲ 23.7% | 202.55M▲ 0% |
| Asset Turnover | 0.60x | 1.44x | 1.47x | 1.02x | 0.94x | 1.06x | 0.86x | 1.00x | 0.80x | 1.16x |
| Asset Growth % | -8.06% | -62.94% | 9.64% | 72.94% | 50.66% | 21.77% | 87.13% | -0.22% | 23.74% | -0.06% |
| Total Current Liabilities | 14.16M | 14.24M | 18.02M | 24.39M | 32.74M | 41.74M | 60.57M | 60.85M | 74.71M | 75.24M |
| Accounts Payable | 6.65M | 4.87M | 6.13M | 7.43M | 9.84M | 13.84M | 24.74M | 29.31M | 38.43M | 38.48M |
| Days Payables Outstanding | 135.36 | 81.77 | 131.25 | 78.14 | 127.51 | 152.11 | 155.94 | 155.21 | 2.32K | 540.09 |
| Short-Term Debt | 0 | 0 | 8.18M | 4.31M | 6.99M | 12.33M | 17.47M | 16.05M | 16.37M | 23.45M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 3.29M | 7.34M | 3.04M | 4.51M | 3.57M | 4.59M | 15.92M |
| Other Current Liabilities | 443.94K | 73.53K | 1.54M | 1.81M | 0 | 0 | 4.93M | 4.58M | 8.27M | 8.88M |
| Current Ratio | 1.30x | 1.25x | 1.29x | 1.86x | 1.75x | 1.00x | 1.08x | 1.20x | 1.05x | 1.05x |
| Quick Ratio | 0.74x | 0.94x | 1.09x | 1.59x | 1.47x | 0.62x | 0.78x | 0.86x | 0.71x | 0.71x |
| Cash Conversion Cycle | 70.64 | 56.34 | 1.17 | 34.63 | 34.94 | 61.92 | 4.94 | -1.57 | -719.69 | -124.51 |
| Total Non-Current Liabilities | 9.26M | 8.85M | 15.42M | 20.06M | 17.21M | 10.93M | 75.72M | 79.21M | 96.48M | 92.42M |
| Long-Term Debt | 5.08M | 5.57M | 11.68M | 18.16M | 12.3M | 3.73M | 61.35M | 64.6M | 82.48M | 91.33M |
| Capital Lease Obligations | 2.95M | 3.29M | 1.04M | 3.23M | 4.78M | 7.2M | 14.03M | 13.32M | 13.04M | 48.73M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 344K | 202K | 287K | 988K |
| Other Non-Current Liabilities | 0 | 0 | 2.71M | -1.33M | 133K | 3.25M | 0 | 1.12M | 670K | -10.09M |
| Total Liabilities | 30.79M | 23.09M | 33.44M | 41.54M | 49.95M | 52.67M | 136.29M | 140.06M | 171.19M | 167.66M |
| Total Debt | 13.24M | 16.33M | 21.32M | 27.74M | 27.05M | 26.56M | 97.96M | 99.8M | 118.79M | 127.35M |
| Net Debt | 10.17M | 12.98M | 11.61M | -1.49M | -7.56M | 23.01M | 80.75M | 83.63M | 7.03M | 116.83M |
| Debt / Equity | 0.18x | 1.09x | 1.47x | 0.98x | 0.46x | 0.33x | 0.88x | 0.93x | 1.06x | 1.06x |
| Debt / EBITDA | - | 2.56x | 3.60x | 2.00x | 1.66x | 0.96x | 2.13x | 1.93x | 2.84x | 2.74x |
| Net Debt / EBITDA | - | 2.04x | 1.96x | -0.11x | -0.46x | 0.83x | 1.76x | 1.62x | 0.17x | 0.17x |
| Interest Coverage | -11.42x | -3.60x | -1.42x | -0.34x | -0.73x | 2.46x | 0.76x | 0.12x | -0.57x | -0.30x |
| Total Equity | 71.76M▲ 0% | 14.91M▼ 79.2% | 14.47M▼ 3.0% | 28.23M▲ 95.2% | 58.62M▲ 107.6% | 79.55M▲ 35.7% | 111.11M▲ 39.7% | 107.19M▼ 3.5% | 112.1M▲ 4.6% | 112.79M▲ 0% |
| Equity Growth % | -21.32% | -79.22% | -3.01% | 95.19% | 107.62% | 35.69% | 39.68% | -3.53% | 4.58% | -2.09% |
| Book Value per Share | 3.81 | 0.74 | 0.70 | 1.24 | 1.93 | 2.14 | 2.79 | 2.52 | 2.59 | 2.59 |
| Total Shareholders' Equity | 71.76M | 14.91M | 17.25M | 28.23M | 58.62M | 79.55M | 111.11M | 107.19M | 100.39M | 100.77M |
| Common Stock | 155.95M | 150.12M | 151.96M | 171.41M | 202.83M | 214.25M | 247.53M | 0 | 0 | 0 |
| Retained Earnings | -106.01M | -159.48M | -215.34M | -159.69M | -165.86M | -161.02M | -163.81M | -170.57M | -181.27M | -182.32M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 8M | 9.54M | 9.82M | 9.91M | 656.03K | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11.7M | 12.04M |
QIPT Cash Flow Statement
Quipt Home Medical Corp. (QIPT) cash flow — operating, investing & free cash flow history
| Line item | Sep'17 | Sep'18 | Sep'19 | Sep'20 | Sep'21 | Sep'22 | Sep'23 | Sep'24 | Sep'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -6.07M | 10.64M | 8.39M | 9.89M | 17.76M | 26.34M | 36.98M | 35.38M | 37.69M | 37.69M |
| Operating CF Margin % | -9.86% | 19.5% | 13.72% | 13.52% | 17.35% | 18.84% | 17.47% | 14.39% | 15.36% | - |
| Operating CF Growth % | -36.03% | 275.42% | -21.18% | 17.92% | 79.52% | 48.33% | 40.37% | -4.32% | 6.53% | 95.29% |
| Net Income | -19.15M | -5.39M | -5.58M | -3.79M | -6.17M | 6.68M | -3.78M | -6.76M | -10.7M | -10.74M |
| Depreciation & Amortization | 12.45M | 12.02M | 10.55M | 10.98M | 17.73M | 23.04M | 41.23M | 50.55M | 51.92M | 52.13M |
| Stock-Based Compensation | -1.21M | 1.29M | 1.56M | 128.44K | 4.95M | 7.59M | 5.28M | 2.48M | 4.04M | 4.81M |
| Deferred Taxes | 0 | 4.06M | 4.3M | 4.96M | -3.8M | 0 | -548K | 342K | 85K | 83K |
| Other Non-Cash Items | 6.04M | 3.04M | 1.39M | 1.12M | 13.9M | -11.72M | -3.19M | -3.54M | -6.56M | -4.76M |
| Working Capital Changes | -4.2M | -4.38M | -3.82M | -3.5M | -8.85M | 758K | -2.01M | -7.7M | -1.08M | -4.13M |
| Change in Receivables | -4.21M | -7M | -5.16M | -3.86M | -8.82M | -201K | -3.06M | -3.29M | 2.58M | 991.21K |
| Change in Inventory | -3.98M | 3.69M | 637.56K | -1.33M | -44K | -2.42M | -60K | -3.42M | -2.42M | -4.45M |
| Change in Payables | 0 | -4.12M | 0 | 1.66M | 518K | 3.35M | 3.12M | 3.13M | -3.41M | -1.63M |
| Cash from Investing | 9.3M | -723.68K | 1.77M | -5.93M | -17.84M | -42.49M | -82.83M | -10.31M | -32.95M | -31.27M |
| Capital Expenditures | -2.44M | -530.18K | -1.36M | -69.02K | -5.05M | -9.16M | -6.85M | -10.31M | -12.35M | -10.75M |
| CapEx % of Revenue | 3.97% | 0.97% | 2.23% | 0.09% | 4.93% | 6.55% | 3.24% | 4.19% | 5.04% | - |
| Acquisitions | -129.78K | -422.6K | 2.97M | -6.05M | -12.89M | -33.52M | -76.04M | -210K | -21.82M | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 11.87M | 229.1K | 161.66K | 190.79K | 98K | 193K | 65K | 210K | 1.23M | -20.53M |
| Cash from Financing | -6.53M | -10.51M | -5.03M | 10.48M | 4.84M | -9.85M | 54.43M | -26.15M | -7.76M | -11.82M |
| Debt Issued (Net) | -1.79M | -10.89M | -8.92M | -6.96M | -12.96M | -5.07M | 27.22M | -25.5M | -7.58M | -11.85M |
| Equity Issued (Net) | 4K | 252K | 1000K | 1000K | 1000K | 523.47K | 1000K | 357.03K | -130.5K | 508.15K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -214.22K | -130.5K | -130.52K |
| Other Financing | -4.75M | 123.7K | 756.65K | -1.75M | -1.21M | -5.3M | -653.79K | -1.01M | -49.35K | -476.95K |
| Net Change in Cash | -2.74M▲ 0% | 727.55K▲ 126.5% | 6.44M▲ 785.0% | 14.66M▲ 127.7% | 5.38M▼ 63.3% | -26.1M▼ 584.6% | 8.69M▲ 133.3% | -1.03M▼ 111.9% | -3.26M▼ 214.8% | -4.91M▲ 0% |
| Free Cash Flow | -7.33M▲ 0% | 10.11M▲ 237.9% | 7.03M▼ 30.5% | 9.82M▲ 39.8% | 13.65M▲ 38.9% | 17.18M▲ 25.9% | 30.13M▲ 75.3% | 25.07M▼ 16.8% | 25.34M▲ 1.1% | 26.69M▲ 0% |
| FCF Margin % | -11.91% | 18.53% | 11.49% | 13.43% | 13.33% | 12.29% | 14.23% | 10.19% | 10.33% | 9.31% |
| FCF Growth % | 0.92% | 237.93% | -30.51% | 39.79% | 38.9% | 25.92% | 75.34% | -16.79% | 1.08% | 17.33% |
| FCF per Share | -0.39 | 0.50 | 0.34 | 0.43 | 0.45 | 0.46 | 0.76 | 0.59 | 0.59 | 0.59 |
| FCF Conversion (FCF/Net Income) | 0.32x | 0.73x | -1.50x | -2.16x | -2.88x | 5.44x | -13.28x | -5.23x | -3.52x | -2.49x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 6.03M | 6.83M | 0 | 1.77M |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 680K | 1.25M | 0 | 0 |
QIPT Key Ratios
Quipt Home Medical Corp. (QIPT) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -23.5% | 33.48% | -37.98% | -21.41% | -14.22% | 7% | -2.92% | -6.2% | -9.76% | -9.52% |
| Return on Invested Capital (ROIC) | -10.78% | -7.23% | -12.86% | -1.8% | -2.81% | 4.77% | 2.98% | 0.44% | -1.4% | -1.4% |
| Gross Margin | 70.86% | 69.17% | 72.11% | 52.54% | 72.48% | 76.25% | 72.65% | 71.97% | 97.53% | 84.47% |
| Net Margin | -31.11% | 26.59% | -9.12% | -6.25% | -6.03% | 3.46% | -1.32% | -2.75% | -4.36% | -3.75% |
| Debt / Equity | 0.18x | 1.09x | 1.47x | 0.98x | 0.46x | 0.33x | 0.88x | 0.93x | 1.06x | 1.06x |
| Interest Coverage | -11.42x | -3.60x | -1.42x | -0.34x | -0.73x | 2.46x | 0.76x | 0.12x | -0.57x | -0.30x |
| FCF Conversion | 0.32x | 0.73x | -1.50x | -2.16x | -2.88x | 5.44x | -13.28x | -5.23x | -3.52x | -2.49x |
| Revenue Growth | -36.09% | -11.35% | 12.07% | 19.63% | 39.88% | 36.65% | 51.35% | 16.17% | -0.23% | 19.78% |
QIPT SEC Filings & Documents
Quipt Home Medical Corp. (QIPT) SEC filings — annual & quarterly reports (10-K, 10-Q)
QIPT Frequently Asked Questions
Quipt Home Medical Corp. (QIPT) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Quipt Home Medical Corp. (QIPT) reported $286.6M in revenue for fiscal year 2025.
Quipt Home Medical Corp. (QIPT) saw revenue decline by 0.2% over the past year.
Quipt Home Medical Corp. (QIPT) reported a net loss of $10.7M for fiscal year 2025.
Dividend & Returns
Quipt Home Medical Corp. (QIPT) has a return on equity (ROE) of -9.8%. Negative ROE indicates the company is unprofitable.
Quipt Home Medical Corp. (QIPT) generated $26.7M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
Explore More QIPT
Quipt Home Medical Corp. (QIPT) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates